Cargando…
The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses an unprecedented global health crisis. It is particularly urgent to develop clinically effective therapies to contain the pandemic. The main protease (M(pro)) and the R...
Autores principales: | Jin, Zhenming, Wang, Haofeng, Duan, Yinkai, Yang, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680044/ https://www.ncbi.nlm.nih.gov/pubmed/33288200 http://dx.doi.org/10.1016/j.bbrc.2020.10.091 |
Ejemplares similares
-
Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
por: Zhao, Yao, et al.
Publicado: (2021) -
Molecular mechanism of ensitrelvir inhibiting SARS-CoV-2 main protease and its variants
por: Lin, Mengmeng, et al.
Publicado: (2023) -
Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2
por: Zhao, Yao, et al.
Publicado: (2022) -
Remdesivir Strongly Binds
to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2:
Evidence from Molecular Simulations
por: Nguyen, Hoang Linh, et al.
Publicado: (2020) -
Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp)
por: da Silva, Felipe Moura A, et al.
Publicado: (2020)